Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corp. of America Holdings operates as an independent clinical laboratory company. Its national network of laboratories offers a broad range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. The company's specialty testing operations comprises of oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical trials. It also provides specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, identity, forensics, infectious disease, oncology and occupational testing. LabCorp laboratories have been at the forefront of new molecular tests to diagnose, treat and manage disease, particularly in the areas of infectious disease, oncology and genetics. The company was founded in 1971 and is headquartered in Burlington, NC.